Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117570 · ClinicalTrials.gov registry record · Phase 2
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
A Phase 2 study of Clostridium Difficile Associated Disease, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 185
- Enrollment target
- 12
- Study locations
NCT02117570 is a Phase 2 study of Clostridium Difficile Associated Disease that has completed, run by Pfizer. The registered enrollment target is 185 participants. The trial reports 12 study locations across 6 states.
The verdict
NCT02117570, a Phase 2 study of Clostridium Difficile Associated Disease, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 185 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study will investigate a Clostridium difficile vaccine in healthy adults aged 50 to 85 years, who will each receive 3 doses of vaccine. The study will assess the safety and tolerability of the vaccine, and also look at the subjects' immune response to the vaccine.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Clostridium difficile vaccine
Study Locations (12)
North Carolina
- PMG Research of Charlotte - Charlotte
- PMG Research of Wilmington, LLC - Wilmington
- PMG Research of Winston-Salem - Winston-Salem
Texas
- Benchmark Research - Austin
- Benchmark Research - San Angelo
- Clinical Trials of Texas, Inc. - San Antonio
Georgia
- Meridian Clinical Research - Savannah
- Clinical Research Atlanta - Stockbridge
Nebraska
- Meridian Clinical Research - Norfolk
- Meridian Clinical Research, LLC - Omaha
Florida
- Avail Clinical Research, LLC - DeLand
Nevada
- Clinical Research Center of Nevada, LLC - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117570
The ClinicalTrials.gov registry entry for NCT02117570 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Clostridium Difficile Associated Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02117570 reports 12 study locations spanning 6 distinct geographic areas - top geographies include North Carolina, Texas, Georgia.
Frequently Asked Questions
What is clinical trial NCT02117570 about?
NCT02117570 is a clinical study titled "A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.". This study will investigate a Clostridium difficile vaccine in healthy adults aged 50 to 85 years, who will each receive 3 doses of vaccine. The study will assess the safety and tolerability of the vaccine, and also look at the subjects' immune response to the vaccine.
What is the current status of trial NCT02117570?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2014-07. Estimated completion is 2015-12.
What conditions does trial NCT02117570 study?
This clinical trial studies the following conditions: Clostridium Difficile Associated Disease.
What interventions are being tested in trial NCT02117570?
The interventions under investigation include: Placebo (BIOLOGICAL), Clostridium difficile vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02117570?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02117570 being conducted?
This trial has 12 study locations across Florida, Georgia, Nebraska, Nevada, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridium Difficile Associated Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years
COMPLETED · Phase 1
-
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.